Skip to search formSkip to main contentSkip to account menu

travoprost

Known as: 5-Heptenoic Acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, 1-methylethyl Ester,(5Z)-, Travoprost [Chemical/Ingredient], Travoprostum 
A synthetic lipophilic isopropyl ester prodrug of the active compound travoprost free acid, a prostaglandin F2alpha analog with anti-glaucoma… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Author(s): Mansouri, Kaweh; Medeiros, Felipe A; Liu, John HK; De Moraes, Carlos G; Weinreb, Robert N 
2011
2011
Purpose: To evaluate “in vivo” the effect of topical travoprost on the central corneal thickness (CCT) of rabbit eyes, and the… 
2010
2010
PurposeTo evaluate 24-h efficacy of travoprost/timolol fixed combination (TTFC) vslatanoprost/timolol fixed combination (LTFC) in… 
2008
2008
Purpose:  To determine whether a topically instilled prostaglandin analogue inhibits endothelin‐1 (ET‐1)‐induced vasoconstrictive… 
2008
2008
Purpose: To compare the subjective symptoms, conjunctival hyperemia, tearing response and conjunctival cytological changes… 
2007
2007
PurposeTo assess the efficacy and safety of systematically switching a large number of hospital-based glaucoma patients from… 
2007
2007
Purpose To analyze quantitative changes in glaucoma treatment strategies between 1997 and 2003 in France. Methods Numbers of ab… 
2006
2006
Purpose:To evaluate the accuracy of a prototype electronic device for recording eye drop usage. Participants and Methods:Ten… 
2006
2006
PURPOSE To compare the effects of travoprost 0.004% and latanoprost 0.005% on the intraocular pressure (IOP) of normal dogs…